Question 1

What is satralizumab?

Accepted Answer

Satralizumab is a humanized monoclonal antibody designed to target and block interleukin-6 (IL-6) receptors. These receptors are part of a signaling pathway that the body uses to trigger inflammation and immune responses.

By binding to these specific receptors, the medication helps regulate immune system activity. This mechanism is intended to interrupt the inflammatory processes associated with certain chronic health conditions.

Question 2

What is satralizumab used for?

Accepted Answer

Satralizumab is used to treat neuromyelitis optica spectrum disorder .

Question 3

How does satralizumab work?

Accepted Answer

Mechanism of Action

Satralizumab belongs to a class of medications known as interleukin-6 (IL-6) receptor antagonists. In people with neuromyelitis optica spectrum disorder (NMOSD), the immune system mistakenly attacks healthy cells in the optic nerves and spinal cord. This process is driven in part by a protein called interleukin-6, which triggers inflammation and immune system activity.

This medication works by:

Binding to receptors: Satralizumab attaches to specific receptors on the surface of cells and in the bloodstream.

Blocking signals: By binding to these receptors, it prevents interleukin-6 from sending signals that cause inflammation.

Reducing attacks: Lowering this inflammatory response helps decrease the frequency and severity of NMOSD relapses.

By controlling the overactive immune response, satralizumab helps protect the nerves from damage caused by the body's own defense system.

Question 4

What are the brand names for satralizumab?

Accepted Answer

satralizumab is sold under the brand name Enspryng .

Question 5

What are the active ingredients in satralizumab?

Accepted Answer

The active ingredient in satralizumab is satralizumab .

Question 6

What are the side effects of satralizumab?

Accepted Answer

Common side effects of satralizumab may include:

upper respiratory tract infection

headache

joint pain

Always consult with a healthcare professional about potential side effects.

Question 7

What drug class is satralizumab?

Accepted Answer

Satralizumab belongs to the monoclonal antibody targeting IL-6 receptor drug class.

Question 8

What is the dosage of satralizumab and how do I take it?

Accepted Answer

How it is given

Satralizumab is administered as a subcutaneous injection, which means it is injected into the fatty tissue just under the skin. It is typically given in the abdomen or the thigh. It is important to rotate the injection site with each dose and avoid areas where the skin is tender, bruised, red, hard, or contains scars or moles.

The treatment schedule usually begins with several initial doses given at specific intervals to build up the level of medicine in the body. After these starting doses, the medication is typically administered once every few weeks as a maintenance dose.

Self-administration

A healthcare provider may determine if it is appropriate for a patient or caregiver to administer the injections at home. Before doing so, a healthcare professional must provide training on the correct way to prepare and inject the medication. The medication should be removed from the refrigerator and allowed to reach room temperature for about 30 minutes before use. The prefilled syringe should not be shaken.

Missed doses

If a dose is missed, it should be administered as soon as it is remembered. You should not wait until the next scheduled dose. Once the missed dose is taken, the schedule for future doses should be adjusted based on the date the missed dose was actually received. Consult a healthcare provider for guidance on resetting the schedule.

Question 9

Is satralizumab safe during pregnancy and breastfeeding?

Accepted Answer

Pregnancy

It is not yet known if satralizumab will harm an unborn baby. While animal studies have not shown harmful effects on the fetus, there is not enough data from human studies to confirm its safety. As a monoclonal antibody, satralizumab is likely to cross the placenta during pregnancy.

Individuals who are pregnant or planning to become pregnant should consult with their healthcare provider to weigh the potential benefits of treatment against any possible risks.

Breastfeeding

It is unknown if satralizumab passes into breast milk or if it could affect a nursing infant or milk production. Because the risks are not well understood, it is recommended to discuss breastfeeding plans with a doctor before starting or continuing treatment.

Question 10

What forms and strengths does satralizumab come in?

Accepted Answer

Dosage Forms

Satralizumab is supplied in the following form:

Injection: A clear, colorless to slightly yellow liquid solution.

Administration Method

This medication is designed for subcutaneous use, meaning it is injected into the fatty tissue just beneath the skin. It is provided in a single-dose prefilled syringe intended for one-time use.

Question 11

What is the FDA approval status of satralizumab?

Accepted Answer

FDA Approval and Indications

The U.S. Food and Drug Administration (FDA) approved satralizumab in August 2020. It is indicated for the treatment of neuromyelitis optica spectrum disorder (NMOSD) in adult patients who are anti-aquaporin-4 (AQP4) antibody positive. It was the first subcutaneous treatment approved for this condition that can be administered by a patient or caregiver at home after training.

Regulatory Requirements and Screenings

Because satralizumab affects the immune system, the FDA-approved labeling requires healthcare providers to complete several screenings before a patient begins treatment:

Antibody Testing: Patients must test positive for the AQP4 antibody, as the medication's effectiveness has not been established in patients who are antibody-negative.

Hepatitis B Screening: Providers must test for Hepatitis B virus (HBV) infection before starting the first dose.

Tuberculosis Screening: Patients must be evaluated for active or latent tuberculosis (TB) infection.

Vaccinations: All required immunizations should be completed according to current guidelines before starting therapy.

Satralizumab does not currently carry a boxed warning or a Risk Evaluation and Mitigation Strategy (REMS) requirement. It is available only by prescription.

Question 12

What should I know about satralizumab and cost?

Accepted Answer

Factors Affecting Cost

The out-of-pocket cost for satralizumab is influenced by several factors:

Insurance Coverage: Your specific health plan, including your deductible and copayment or coinsurance amounts, will determine how much you pay.

Prior Authorization: Most insurance providers require a prior authorization process. This means your doctor must provide documentation to your insurance company to prove the medication is medically necessary before they will cover the cost.

Specialty Pharmacy: Satralizumab is a specialty medication and is typically dispensed through specialty pharmacies rather than standard retail pharmacies, which can affect pricing and delivery.

Generic and Biosimilar Availability

There is currently no generic or biosimilar version of satralizumab available. As a biologic medication, it is protected by patents that prevent other companies from making lower-cost versions for a set period of time.

Financial Assistance

The manufacturer may offer support programs to help patients manage the cost of the medication. These may include:

Copay Cards: Eligible patients with commercial insurance may be able to use a copay card to reduce their monthly out-of-pocket expenses.

Patient Assistance Programs: Individuals who are uninsured or underinsured may qualify for programs that provide the medication at a reduced cost or for free, based on financial need.

It is recommended to speak with your healthcare provider or contact your insurance company directly to understand the specific costs associated with your treatment plan.

satralizumab

Medication Quick Facts

📋Overview

What It's Used For

How It Works

Brand Names

Side Effects

Warnings & Precautions

Dosage & How to Take

Pregnancy & Breastfeeding

Forms & Strengths

FDA / Regulatory Status

Price Information

FAQ

Additional Resources

Support & Help Resources

Found an Error?